Transmitter‐Gated Channels

[1]  J A Peters,et al.  Guide to Receptors and Channels (GRAC), 2nd edition (2007 Revision). , 2007, British journal of pharmacology.

[2]  M. Zoli,et al.  Brain nicotinic acetylcholine receptors: native subtypes and their relevance. , 2006, Trends in pharmacological sciences.

[3]  S. Sine,et al.  Recent advances in Cys-loop receptor structure and function , 2006, Nature.

[4]  P. Chameau,et al.  Serotonin 5-HT(3) receptors in the central nervous system. , 2006, Cell and tissue research.

[5]  R. Callister,et al.  Glycine receptors: a new therapeutic target in pain pathways. , 2006, Current opinion in investigational drugs.

[6]  T. Liljefors,et al.  Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. , 2005, Journal of medicinal chemistry.

[7]  C. Glover,et al.  Gene expression profiling for hematopoietic cell culture , 2006 .

[8]  R. W. Janes.  alpha-Conotoxins as selective probes for nicotinic acetylcholine receptor subclasses. , 2005, Current opinion in pharmacology.

[9]  J. Henley,et al.  The Molecular Pharmacology and Cell Biology of α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Receptors , 2005, Pharmacological Reviews.

[10]  N. Unwin,et al.  Refined structure of the nicotinic acetylcholine receptor at 4A resolution. , 2005, Journal of molecular biology.

[11]  P. Illés,et al.  P2X and P2Y receptors as possible targets of therapeutic manipulations in CNS illnesses. , 2005, Drug news & perspectives.

[12]  E. Waxman,et al.  N-methyl-D-aspartate Receptor Subtypes: Multiple Roles in Excitotoxicity and Neurological Disease , 2005, The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry.

[13]  C. Gotti,et al.  Neuronal nicotinic receptors: from structure to pathology , 2004, Progress in Neurobiology.

[14]  F. Di Virgilio,et al.  Agonists and antagonists acting at P2X7 receptor. , 2004, Current topics in medicinal chemistry.

[15]  J. Lynch,et al.  Molecular structure and function of the glycine receptor chloride channel. , 2004, Physiological reviews.

[16]  R. Evans,et al.  Molecular properties of ATP-gated P2X receptor ion channels. , 2004, Trends in pharmacological sciences.

[17]  S. Wonnacott,et al.  Nicotinic acetylcholine receptors and the regulation of neuronal signalling. , 2004, Trends in pharmacological sciences.

[18]  R. Lewis,et al.  Alpha-conotoxins as tools for the elucidation of structure and function of neuronal nicotinic acetylcholine receptor subtypes. , 2004, European journal of biochemistry.

[19]  L. Wollmuth,et al.  Structure and gating of the glutamate receptor ion channel , 2004, Trends in Neurosciences.

[20]  E. Nisenbaum,et al.  AMPA receptor potentiators for the treatment of CNS disorders. , 2004, Current drug targets. CNS and neurological disorders.

[21]  Martyn P Mahaut-Smith,et al.  Emerging roles for P2X1 receptors in platelet activation , 2004, Platelets.

[22]  D Bertrand,et al.  Nicotinic acetylcholine receptors as drug targets. , 2004, Current drug targets. CNS and neurological disorders.

[23]  M. Mayer,et al.  Structure and function of glutamate receptor ion channels. , 2004, Annual review of physiology.

[24]  J. Changeux,et al.  Knockout and knockin mice to investigate the role of nicotinic receptors in the central nervous system. , 2002, Progress in brain research.

[25]  M. Dart,et al.  Design of ligands for the nicotinic acetylcholine receptors: the quest for selectivity. , 2004, Current topics in medicinal chemistry.

[26]  R. Nicoll,et al.  AMPA Receptor Trafficking at Excitatory Synapses , 2003, Neuron.

[27]  T. Sixma,et al.  Structure and Function of AChBP, Homologue of the Ligand‐Binding Domain of the Nicotinic Acetylcholine Receptor , 2003, Annals of the New York Academy of Sciences.

[28]  J. E. Huettner.  Kainate receptors and synaptic transmission , 2003, Progress in Neurobiology.

[29]  Juan Lerma,et al.  Roles and rules of kainate receptors in synaptic transmission , 2003, Nature Reviews Neuroscience.

[30]  J. A. van Hooft,et al.  5-HT3 receptors in the CNS: 3B or not 3B? , 2003, Trends in pharmacological sciences.

[31]  D. Bertrand,et al.  Nicotinic acetylcholine receptors: from structure to brain function. , 2003, Reviews of physiology, biochemistry and pharmacology.

[32]  A. Janowsky,et al.  The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications. , 2003, Pharmacology & therapeutics.

[33]  C. Becker,et al.  The Inhibitory Glycine Receptor—Simple Views of a Complicated Channel , 2002, Chembiochem : a European journal of chemical biology.

[34]  Heinrich Betz,et al.  Modulation of glycine receptor function: a novel approach for therapeutic intervention at inhibitory synapses? , 2002, Trends in pharmacological sciences.

[35]  K. Jacobson,et al.  Purine and pyrimidine (P2) receptors as drug targets. , 2002, Journal of medicinal chemistry.

[36]  S. Lummis,et al.  The molecular basis of the structure and function of the 5-HT 3 receptor: a model ligand-gated ion channel (Review) , 2002, Molecular membrane biology.

[37]  G Burnstock,et al.  Potential therapeutic targets in the rapidly expanding field of purinergic signalling. , 2002, Clinical medicine.

[38]  Mark Farrant,et al.  NMDA receptor subunits: diversity, development and disease , 2001, Current Opinion in Neurobiology.

[39]  S. Moss,et al.  Constructing inhibitory synapses , 2001, Nature Reviews Neuroscience.

[40]  B. Khakh.  Molecular physiology of p2x receptors and atp signalling at synapses , 2001, Nature Reviews Neuroscience.

[41]  B S Khakh,et al.  International union of pharmacology. XXIV. Current status of the nomenclature and properties of P2X receptors and their subunits. , 2001, Pharmacological reviews.

[42]  R. Harvey,et al.  Structures, Diversity and Pharmacology of Glycine Receptors and Transporters , 2001 .

[43]  G. Burnstock,et al.  P2 purinergic receptors: modulation of cell function and therapeutic potential. , 2000, The Journal of pharmacology and experimental therapeutics.

[44]  M. Kneussel,et al.  Clustering of inhibitory neurotransmitter receptors at developing postsynaptic sites: the membrane activation model , 2000, Trends in Neurosciences.

[45]  P. Illés,et al.  Neuronal P2X receptors: localisation and functional properties , 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

[46]  M. Williams,et al.  Purinergic and pyrimidinergic receptors as potential drug targets. , 2000, Biochemical pharmacology.

[47]  H. Tse,et al.  Glutamate receptor ion channels : Activators and inhibitors , 2000 .

[48]  J. Changeux,et al.  Nicotinic receptors at the amino acid level. , 2000, Annual review of pharmacology and toxicology.

[49]  R. North,et al.  Pharmacology of cloned P2X receptors. , 2000, Annual review of pharmacology and toxicology.

[50]  T. Yamakura,et al.  Subunit- and site-specific pharmacology of the NMDA receptor channel , 1999, Progress in Neurobiology.

[51]  D. Lovinger.  5-HT3 receptors and the neural actions of alcohols: an increasingly exciting topic , 1999, Neurochemistry International.

[52]  Trevor Sharp,et al.  A review of central 5-HT receptors and their function , 1999, Neuropharmacology.

[53]  J P Changeux,et al.  International Union of Pharmacology. XX. Current status of the nomenclature for nicotinic acetylcholine receptors and their subunits. , 1999, Pharmacological reviews.

[54]  R. Harvey,et al.  Structure and Functions of Inhibitory and Excitatory Glycine Receptors , 1999, Annals of the New York Academy of Sciences.

[55]  P. Schofield,et al.  Structure‐Function Relationships of the Human Glycine Receptor: Insights from Hyperekplexia Mutations , 1999, Annals of the New York Academy of Sciences.

[56]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[57]  Nicolas Le Novère,et al.  The Ligand Gated Ion Channel Database , 1999, Nucleic Acids Res..

[58]  P. Jonas,et al.  Ionotropic Glutamate Receptors in the CNS , 1999, Handbook of Experimental Pharmacology.

[59]  C. Parsons,et al.  Glycine and N-methyl-D-aspartate receptors: physiological significance and possible therapeutic applications. , 1998, Pharmacological reviews.

[60]  M. J. Browne.  Recombinant Cell Surface Receptors: Focal Point For Therapeutic Intervention , 1997 .

[61]  P. Schofield,et al.  The glycine receptor. , 1997, Pharmacology & therapeutics.

[62]  N. Barnes,et al.  Allosteric modulation of 5-HT3 receptors: focus on alcohols and anaesthetic agents. , 1996, Trends in pharmacological sciences.

[63]  G. Martin,et al.  Alignment of receptor nomenclature with the human genome: classification of 5-HT1B and 5-HT1D receptor subtypes. , 1996, Trends in pharmacological sciences.

[64]  P P Humphrey,et al.  International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). , 1994, Pharmacological reviews.

[65]  Gavin Kilpatrick,et al.  5-HT 3 Receptors , 1993 .

[66]  Burton S. Rosner,et al.  Neuropharmacology , 1958, Nature.

[67]  P. Illés,et al.  Neuronal P 2 X receptors : localisation and functional properties , 2022 .